12:00 AM
 | 
Jul 24, 2000
 |  BC Week In Review  |  Company News  |  Deals

Avax, Genopoietic S.A. deal

AVXT will acquire Genopoietic, which develops cell and gene therapies for cartilage repair, cancer, and graft-versus-host disease. Genopoietic will become a wholly owned subsidiary of AVXT for up to...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >